Considerations for cancer immunotherapy during the COVID-19 pandemic

Med J Aust. 2020 Nov;213(9):390-392.e1. doi: 10.5694/mja2.50805. Epub 2020 Oct 8.

Authors

Yada Kanjanapan^{1

2}, Desmond Yip^{1

2}

Affiliations

¹ Canberra Hospital, Canberra, ACT.
² Australian National University, Canberra, ACT.

No abstract available

Keywords: COVID-19; Cancer; Immunotherapies; Infectious diseases; Respiratory tract infections.

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections / complications*
Coronavirus Infections / epidemiology
Humans
Immunotherapy / adverse effects*
Immunotherapy / methods
Neoplasms / complications*
Neoplasms / therapy*
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / epidemiology
SARS-CoV-2